Natera, Inc. (NASDAQ:NTRA) Q4 2024 Earnings Call Transcript
Operator: Welcome everyone to Natera's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 4,431,609 | $701,523,705 | -3% | 3.55% |
| 2. | Kynam Capital Derrick Tang | 2,022,098 | $320,098,113 | -1% | 18.92% |
| 3. | Citadel Investment Group Ken Griffin | 1,430,968 | $226,522,234 | -38% | 0.03% |
| 4. | Maverick Capital Lee Ainslie | 1,366,054 | $216,246,348 | +2% | 3.89% |
| 5. | Castle Hook Partners Josh Donfeld And David Rogers | 1,222,578 | $193,534,097 | +8% | 2.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | 420,000 | 2022-05-12 | Filing | ||
| $28.81 | 159,783 | 400,989 | 2022-05-12 | Filing | ||
| $28.09 | 41,026 | 241,026 | 2022-05-12 | Filing | ||
| $33.49 | 40,695 | Director | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | Director | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $162.64 | 96 | 43,282 | 2025-02-26 | Filing | ||
| $161.64 | 296 | 43,378 | 2025-02-26 | Filing | ||
| $160.85 | 744 | 43,674 | 2025-02-26 | Filing | ||
| $158.88 | 292 | 44,418 | 2025-02-26 | Filing | ||
| $155.66 | 72 | 44,710 | 2025-02-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,316,470 | $1,949,697,202 | 0.03% | |
| 2. | 9,180,463 | $1,453,267,328 | 0.02% | |
| 3. | 6,701,425 | $1,060,835,694 | 0.07% | |
| 4. | 3,240,041 | $512,898,491 | 0.09% | |
| 5. | 3,017,816 | $477,720,273 | 2.27% |
News See All
Joe DiMenna’s Stock Portfolio: Top 10 Stocks to Buy
Zweig-DiMenna Associates Inc. is a U.S.-based hedge fund with a legacy spanning four decades. Established in 1984 by Joseph A.
Natera (NTRA) Surged on Blowout Quarterly Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Here’s Why Natera (NTRA) Surged in Q4
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.
Billionaire Stanley Druckenmiller’s Top 10 Stock Picks
On November 6, billionaire Stanley Druckenmiller appeared in a podcast, In Good Company, hosted by Nicolai Tangen, CEO of Norges Bank Investment Management.
Strong Volume Growth Lifted Natera (NTRA) in Q3
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Natera, Inc. (NASDAQ:NTRA) Q3 2024 Earnings Call Transcript
Operator: Welcome to Natera's 2024 Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Performing NASDAQ Stocks in 2024
Fed's recent cut has resulted in significant outperformance in the tech sector, signaling a positive sentiment among investors.
Should You Be Confident in the Growth Potential of Natera (NTRA)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
